Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Health Catalyst, Inc.HCAT · Entity 1565 | Director | June 12, 2020 | June 17, 2020 |
| Natera, Inc.NTRA · Entity 2635 | Director | May 25, 2022 | May 27, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Health Catalyst, Inc.
Report date June 12, 2020 · Filed June 17, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 139,774 |
Reported balance
After 2020-06-12 transaction · row 1
1 source rowRow 1 · 2020-06-12 · Grant · Acquired 5,443 · Balance 139,774 F1: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the date of the next Annual Meeting of the Issuer's Stockholders. |
| Common StockSEC Table I · non-derivative | IndirectBy Matoaka, LLC | 147,415 |
Reported balance
Holding disclosure · report date 2020-06-12 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 147,415 F2: The shares are held by Matoaka, LLC and the Reporting Person holds the voting and dispositive power over the shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the date of the next Annual Meeting of the Issuer's Stockholders.
F2: The shares are held by Matoaka, LLC and the Reporting Person holds the voting and dispositive power over the shares.
Natera, Inc.
Report date May 25, 2022 · Filed May 27, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,813 |
Reported balance
After 2022-05-25 transaction · row 1
1 source rowRow 1 · 2022-05-25 · Exercise / conversion · Acquired 2,614 · Balance 15,813 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-05-25 · Exercise / conversion · Disposed 2,614 · Balance 0 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2: The RSU vested in full on May 25, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2: The RSU vested in full on May 25, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 25, 2022 Filed May 27, 2022 21:45 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionRestricted Stock Unit · Derivative | 2,614 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005860 · form4-05272022_090515.xml · derivative · entry 2 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,614 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSU vested in full on May 25, 2022. F2 · derivative.expiration_date: The RSU vested in full on May 25, 2022. Read SEC document |
| May 25, 2022 Filed May 27, 2022 21:45 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionCommon Stock | 2,614 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-005860 · form4-05272022_090515.xml · nonDerivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| September 02, 2021 Filed Sep 4, 2021 01:49 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionStock Option (right to buy) · Derivative | 10,578 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0001415889-21-004258 · form4-09032021_060935.xml · derivative · entry 9 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 591 Underlying: Common Stock · 10,578 shares Expires 2027-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option shares vested fully and became exercisable on May 16, 2018. Read SEC document |
| September 02, 2021 Filed Sep 4, 2021 01:49 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionStock Option (right to buy) · Derivative | 11,169 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001415889-21-004258 · form4-09032021_060935.xml · derivative · entry 8 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,169 shares Expires 2026-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option shares vested fully and became exercisable on May 23, 2017. Read SEC document |
| September 02, 2021 Filed Sep 4, 2021 01:49 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionStock Option (right to buy) · Derivative | 2,733 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-21-004258 · form4-09032021_060935.xml · derivative · entry 7 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,733 shares Expires 2023-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option shares vested fully and became exercisable on March 21, 2021. Read SEC document |
| September 02, 2021 Filed Sep 4, 2021 01:49 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 4,764 | $122.71 | $584,570.43 |
DisclosureSEC source: 0001415889-21-004258 · form4-09032021_060935.xml · nonDerivative · entry 6 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,865 F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.50 to $123.1050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 02, 2021 Filed Sep 4, 2021 01:49 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 10,666 | $121.96 | $1,300,861.62 |
DisclosureSEC source: 0001415889-21-004258 · form4-09032021_060935.xml · nonDerivative · entry 5 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,963 F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.50 to $122.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 02, 2021 Filed Sep 4, 2021 01:49 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 8,841 | $120.96 | $1,069,427.69 |
DisclosureSEC source: 0001415889-21-004258 · form4-09032021_060935.xml · nonDerivative · entry 4 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,629 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.48 to $121.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 02, 2021 Filed Sep 4, 2021 01:49 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionCommon Stock | 10,578 | $10.41 | $110,116.98 |
DisclosureSEC source: 0001415889-21-004258 · form4-09032021_060935.xml · nonDerivative · entry 3 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2021 Filed Sep 4, 2021 01:49 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionCommon Stock | 11,169 | $11.80 | $131,794.20 |
DisclosureSEC source: 0001415889-21-004258 · form4-09032021_060935.xml · nonDerivative · entry 2 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2021 Filed Sep 4, 2021 01:49 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionCommon Stock | 2,733 | $1.39 | $3,786.57 |
DisclosureSEC source: 0001415889-21-004258 · form4-09032021_060935.xml · nonDerivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 21:57 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionStock Option (right to buy) · Derivative | 28,650 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-21-003018 · form4-06152021_020630.xml · derivative · entry 3 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,733 Underlying: Common Stock · 28,650 shares Expires 2023-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option shares are fully vested and may be exercised at any time. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 21:57 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 28,650 | $104.00 | $2,979,660.17 |
DisclosureSEC source: 0001415889-21-003018 · form4-06152021_020630.xml · nonDerivative · entry 2 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,990 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.00 to $104.04 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 21:57 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionCommon Stock | 28,650 | $1.39 | $39,694.58 |
DisclosureSEC source: 0001415889-21-003018 · form4-06152021_020630.xml · nonDerivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2021 Filed Jun 3, 2021 00:00 UTC | Natera, Inc. NTRA · Entity 2635 | GrantRestricted Stock Unit · Derivative | 2,614 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-002770 · form4-06022021_050610.xml · derivative · entry 3 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,614 Underlying: Common Stock · 2,614 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The RSU shall vest in full on May 25, 2022. The RSU will become fully vested in the event that the Issuer is subject to a change in control. F3 · derivative.expiration_date: The RSU shall vest in full on May 25, 2022. The RSU will become fully vested in the event that the Issuer is subject to a change in control. Read SEC document |
| May 28, 2021 Filed Jun 3, 2021 00:00 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionRestricted Stock Unit · Derivative | 5,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-002770 · form4-06022021_050610.xml · derivative · entry 2 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,712 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSU vested in full on May 28, 2021. F2 · derivative.expiration_date: The RSU vested in full on May 28, 2021. Read SEC document |
| May 28, 2021 Filed Jun 3, 2021 00:00 UTC | Natera, Inc. NTRA · Entity 2635 | GrantCommon Stock | 5,712 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-21-002770 · form4-06022021_050610.xml · nonDerivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,990 F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 00:23 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 10,717 | $103.97 | $1,114,214.34 |
DisclosureSEC source: 0001415889-21-001454 · form4-03112021_040305.xml · nonDerivative · entry 5 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,278 F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.71 to $104.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 00:23 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 9,283 | $103.38 | $959,657.97 |
DisclosureSEC source: 0001415889-21-001454 · form4-03112021_040305.xml · nonDerivative · entry 4 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,995 F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.70 to $103.69 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 00:23 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionCommon Stock | 20,000 | $1.39 | $27,710.00 |
DisclosureSEC source: 0001415889-21-001454 · form4-03112021_040305.xml · nonDerivative · entry 3 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 00:23 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionStock Option (right to buy) · Derivative | 29,475 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-21-001454 · form4-03112021_040305.xml · derivative · entry 6 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,383 Underlying: Common Stock · 29,475 shares Expires 2023-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests in 48 equal monthly installments beginning on April 21, 2013. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 00:23 UTC | Natera, Inc. NTRA · Entity 2635 | SaleCommon Stock | 29,475 | $100.35 | $2,957,875.20 |
DisclosureSEC source: 0001415889-21-001454 · form4-03112021_040305.xml · nonDerivative · entry 2 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,278 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.98 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 00:23 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionCommon Stock | 29,475 | $1.39 | $40,837.61 |
DisclosureSEC source: 0001415889-21-001454 · form4-03112021_040305.xml · nonDerivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2021 Filed Mar 12, 2021 00:23 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001415889-21-001454 · form4-03112021_040305.xml · derivative · entry 7 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,383 Underlying: Common Stock · 20,000 shares Expires 2023-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests in 48 equal monthly installments beginning on April 21, 2013. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 22:43 UTC | Natera, Inc. NTRA · Entity 2635 | GrantRestricted Stock Units · Derivative | 5,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-007465 · edgar.xml · derivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,712 Underlying: Common Stock · 5,712 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: The RSU shall vest in full on May 28, 2021. The RSU will become fully vested in the event that the Issuer is subject to a change in control. F2 · derivative.expiration_date: The RSU shall vest in full on May 28, 2021. The RSU will become fully vested in the event that the Issuer is subject to a change in control. Read SEC document |
| June 12, 2020 Filed Jun 17, 2020 19:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 5,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004560 · primarydocument.xml · nonDerivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,774 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the date of the next Annual Meeting of the Issuer's Stockholders. Read SEC document |
| April 23, 2020 Filed May 5, 2020 19:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | OtherCommon Stock | 674 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003396 · primarydocument.xml · nonDerivative · entry 10 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Matoaka, LLC Disclosed balance after: 147,415 F1 · kind: Represents a pro rata distribution for no consideration. F2 · ownership.nature: The shares are held by Matoaka, LLC and Reporting Person holds the voting and dispositive power over the shares. Read SEC document |
| April 21, 2020 Filed May 5, 2020 19:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | OtherCommon Stock | 674 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003396 · primarydocument.xml · nonDerivative · entry 9 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Matoaka, LLC Disclosed balance after: 146,741 F1 · kind: Represents a pro rata distribution for no consideration. F2 · ownership.nature: The shares are held by Matoaka, LLC and Reporting Person holds the voting and dispositive power over the shares. Read SEC document |
| April 17, 2020 Filed May 5, 2020 19:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | OtherCommon Stock | 674 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003396 · primarydocument.xml · nonDerivative · entry 8 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Matoaka, LLC Disclosed balance after: 146,067 F1 · kind: Represents a pro rata distribution for no consideration. F2 · ownership.nature: The shares are held by Matoaka, LLC and Reporting Person holds the voting and dispositive power over the shares. Read SEC document |
| April 14, 2020 Filed May 5, 2020 19:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | OtherCommon Stock | 674 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003396 · primarydocument.xml · nonDerivative · entry 7 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Matoaka, LLC Disclosed balance after: 145,393 F1 · kind: Represents a pro rata distribution for no consideration. F2 · ownership.nature: The shares are held by Matoaka, LLC and Reporting Person holds the voting and dispositive power over the shares. Read SEC document |
| April 13, 2020 Filed May 5, 2020 19:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | OtherCommon Stock | 674 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003396 · primarydocument.xml · nonDerivative · entry 6 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Matoaka, LLC Disclosed balance after: 144,719 F1 · kind: Represents a pro rata distribution for no consideration. F2 · ownership.nature: The shares are held by Matoaka, LLC and Reporting Person holds the voting and dispositive power over the shares. Read SEC document |
| March 04, 2020 Filed May 5, 2020 19:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | OtherCommon Stock | 674 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003396 · primarydocument.xml · nonDerivative · entry 5 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Matoaka, LLC Disclosed balance after: 144,045 F1 · kind: Represents a pro rata distribution for no consideration. F2 · ownership.nature: The shares are held by Matoaka, LLC and Reporting Person holds the voting and dispositive power over the shares. Read SEC document |
| February 28, 2020 Filed May 5, 2020 19:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | OtherCommon Stock | 674 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003396 · primarydocument.xml · nonDerivative · entry 4 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Matoaka, LLC Disclosed balance after: 143,371 F1 · kind: Represents a pro rata distribution for no consideration. F2 · ownership.nature: The shares are held by Matoaka, LLC and Reporting Person holds the voting and dispositive power over the shares. Read SEC document |
| February 26, 2020 Filed May 5, 2020 19:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | OtherCommon Stock | 674 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003396 · primarydocument.xml · nonDerivative · entry 3 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Matoaka, LLC Disclosed balance after: 142,697 F1 · kind: Represents a pro rata distribution for no consideration. F2 · ownership.nature: The shares are held by Matoaka, LLC and Reporting Person holds the voting and dispositive power over the shares. Read SEC document |
| February 10, 2020 Filed May 5, 2020 19:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | OtherCommon Stock | 674 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003396 · primarydocument.xml · nonDerivative · entry 2 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Matoaka, LLC Disclosed balance after: 142,023 F1 · kind: Represents a pro rata distribution for no consideration. F2 · ownership.nature: The shares are held by Matoaka, LLC and Reporting Person holds the voting and dispositive power over the shares. Read SEC document |
| January 27, 2020 Filed May 5, 2020 19:27 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | OtherCommon Stock | 674 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003396 · primarydocument.xml · nonDerivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Matoaka, LLC Disclosed balance after: 141,349 F1 · kind: Represents a pro rata distribution for no consideration. F2 · ownership.nature: The shares are held by Matoaka, LLC and Reporting Person holds the voting and dispositive power over the shares. Read SEC document |
| July 29, 2019 Filed Jul 29, 2019 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | ConversionSeries E Preferred Stock · Derivative | 943,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-009172 · wf-form4_156444847869001.xml · derivative · entry 6 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 943,484 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series E Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F4 · price: Each share of Series E Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F4 · derivative.exercise_date: Each share of Series E Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F4 · derivative.expiration_date: Each share of Series E Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. Read SEC document |
| July 29, 2019 Filed Jul 29, 2019 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | ConversionSeries D Preferred Stock · Derivative | 6,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-009172 · wf-form4_156444847869001.xml · derivative · entry 5 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,344 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F2 · price: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F2 · derivative.exercise_date: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F2 · derivative.expiration_date: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. Read SEC document |
| July 29, 2019 Filed Jul 29, 2019 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | ConversionSeries C Preferred Stock · Derivative | 43,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-009172 · wf-form4_156444847869001.xml · derivative · entry 4 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 43,967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F1 · price: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F1 · derivative.exercise_date: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F1 · derivative.expiration_date: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. Read SEC document |
| July 29, 2019 Filed Jul 29, 2019 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | ConversionCommon Stock | 943,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-009172 · wf-form4_156444847869001.xml · nonDerivative · entry 3 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Leerink Transformation Fund I, L. P. Disclosed balance after: 1,084,159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each share of Series E Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F5 · ownership.nature: The shares are held by Leerink Transformation Fund I, L.P. ("Leerink") and the Reporting Person is a co-founder and Managing Partner of Leerink and holds voting and dispositive power over the shares. Read SEC document |
| July 29, 2019 Filed Jul 29, 2019 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | ConversionCommon Stock | 6,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-009172 · wf-form4_156444847869001.xml · nonDerivative · entry 2 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Matoaka, LLC Disclosed balance after: 140,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each share of Series D Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. F3 · ownership.nature: The shares are held by Matoaka, LLC and the Reporting Person holds the voting and dispositive power over the shares. Read SEC document |
| July 29, 2019 Filed Jul 29, 2019 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | ConversionCommon Stock | 43,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-009172 · wf-form4_156444847869001.xml · nonDerivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series C Preferred Stock automatically converted to common stock immediately prior to the closing of the Issuer's initial public offering on a one-for-one basis, and had no expiration date. Read SEC document |
| May 24, 2019 Filed May 29, 2019 22:14 UTC | Natera, Inc. NTRA · Entity 2635 | GrantStock Option (right to buy) · Derivative | 22,000 | $0.00 Strike: $22.83 | $0.00 |
DisclosureSEC source: 0001179110-19-006813 · edgar.xml · derivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2029-05-23 F1 · derivative.exercise_date: The option shares will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (May 24, 2019) or (y) the date of the annual stockholder meeting next following the grant. The option shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| May 16, 2019 Filed Nov 27, 2019 23:09 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionRestricted Stock Unit · Derivative | 7,278 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-012130 · edgar.xml · derivative · entry 2 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,278 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the common stock of the issuer. F3 · derivative.exercise_date: The RSUs vested in full as of the date of the annual stockholder meeting, May 16, 2019. F3 · derivative.expiration_date: The RSUs vested in full as of the date of the annual stockholder meeting, May 16, 2019. Read SEC document |
| May 16, 2019 Filed Nov 27, 2019 23:09 UTC | Natera, Inc. NTRA · Entity 2635 | Exercise / conversionCommon Stock | 7,278 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-012130 · edgar.xml · nonDerivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the full vesting and settlement of Restricted Stock Units ("RSUs"), on May 16, 2019. F2 · price: Each RSU represents a contingent right to receive one share of the common stock of the issuer. Read SEC document |
| April 12, 2019 Filed Apr 23, 2019 21:36 UTC | Natera, Inc. NTRA · Entity 2635 | GrantRestricted Stock Units · Derivative | 7,278 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005128 · edgar.xml · derivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,278 Underlying: Common Stock · 7,278 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Common Stock of the Issuer. F2 · derivative.exercise_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (April 12, 2019) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. F2 · derivative.expiration_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (April 12, 2019) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:45 UTC | Natera, Inc. NTRA · Entity 2635 | GrantRestricted Stock Units · Derivative | 5,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-011538 · edgar.xml · derivative · entry 2 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,785 Underlying: Common Stock · 5,785 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Common Stock of the Issuer. F3 · derivative.exercise_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. F3 · derivative.expiration_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:45 UTC | Natera, Inc. NTRA · Entity 2635 | GrantStock Option (right to buy) · Derivative | 11,169 | $0.00 Strike: $24.42 | $0.00 |
DisclosureSEC source: 0001179110-18-011538 · edgar.xml · derivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,169 Underlying: Common Stock · 11,169 shares Expires 2028-09-13 F1 · derivative.exercise_date: The option shares will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The option shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
| September 14, 2018 Filed Apr 23, 2019 21:35 UTC Amendment | Natera, Inc. NTRA · Entity 2635 | GrantRestricted Stock Units · Derivative | 5,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005127 · edgar.xml · derivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,785 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Common Stock of the Issuer. F2 · derivative.exercise_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. F2 · derivative.expiration_date: The RSUs will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (September 14, 2018) or (y) the date of the annual stockholder meeting next following the grant. The RSU shares will become fully vested and exercisable in the event that the Company is subject to a change in control. F3 · balance_after: The grant of Restricted Stock Units on September 14, 2018 were not granted on September 14, 2018 and was reported in error. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 23:20 UTC | Natera, Inc. NTRA · Entity 2635 | GrantStock Option (right to buy) · Derivative | 11,169 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0001179110-17-009018 · edgar.xml · derivative · entry 1 Cozzens Todd C · CIK 0001382487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,169 Underlying: Common Stock · 11,169 shares Expires 2027-06-08 F1 · derivative.exercise_date: The option shares will vest and become exercisable in full on the earlier of (x) the date that is 12 months following the date of grant (June 9, 2017) or (y) the date of the annual stockholder meeting next following the grant. The option shares will become fully vested and exercisable in the event that the Company is subject to a change in control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.